Brief: Oragenics Extends Collaboration With National Research Council Of Canada To Develop Vaccine Against Omicron Variant
Authors A Publication Describing The Dual Mechanism Of Action Of Lantibiotics
Oragenics gains on positive pre-clinical COVID-19 vaccine study results
Brief: Oragenics Announces Positive Covid-19 Challenge Study Results Evaluating Multiple Formulations Of Its Sars-Cov-2 Vaccine Candidate
Brief: Oragenics Adjourns Shareholders Annual Meeting Due To Lack Of Quorum
U.S. RESEARCH ROUNDUP- Fluence Energy, Informatica, Solo Brands
Brief: Oragenics Awarded A $250,000 Grant From The National Institute Of General Medical Sciences
Brief: Oragenics Says Mutually Terminated Lantibiotic Agreement With Eleszto Genetika
Brief: Oragenics Initiates COVID-19 Challenge Study Testing Multiple Formulations Of Its Vaccine Candidate
Oragenics climbs as COVID-19 spike protein produces antibodies in mice
Brief: Oragenics’ Sars-Cov-2 Spike Protein Produces Neutralizing Antibodies In Mice With Intramuscular And Intranasal Adjuvants
U.S. RESEARCH ROUNDUP- Doximity, Roblox, Talos Energy
Brief: Oragenics Announces Postponement Of Annual Meeting Of Shareholders
U.S. STOCKS ON THE MOVE-UPS, F5 Networks, Oragenics, Centene
Oragenics surges after licensing tech to develop new COVID-19 vaccines
Brief: Oragenics Enters Into Licensing Agreement With The National Research Council Of Canada, To Pursue The Rapid Development Of Next-Generation Sars-Cov-2 Vaccines
Brief: Oragenics Issues Letter To Shareholders
U.S. RESEARCH ROUNDUP- Amgen, Lion Electric, UiPath
Brief: Oragenics Announce Changes In Management And Board Of Directors